Collaborative Intravenous Nursing Service (CINS) Guidelines

More documents

Recommendations

Info

3• To ensure that individuals caring for venous access devices have completed aCheshire and Merseyside North West Strategic Health Authority agreed trainingprogramme.• To ensure that those individuals caring for venous access devices have received anupdate within the last 6 months.• To develop an expert group that will ensure that the best evidence based practice isavailable.The CINs group hereby assert their moral rights tothe works herein in accordance with the Data Protection Act 1988.Policy review date 01/10/10
4Cheshire and Merseyside NHS North WestVenous Access Clinical GroupTerms of ReferenceThe purpose of the group is to ensure that all nurses with relevant competencies acrossCheshire and Merseyside North West Strategic Health Authority utilise universal guidelines,competencies and training.• To act as the primary source of advice on issues relating to the care andmaintenance of venous access devices (VADs).• To ensure co-ordination and consistency across Cheshire and Merseyside NorthWest Strategic Health Authority for the implementation of policies and guidelines.• To implement consistent clinical competencies for VADs.• To collaborate with workforce and education stakeholders to ensure theavailability of the VAD training programme and facilitate ease of access forclinical staff.• To develop and implement guidelines and policies relating to the trainingprogramme.• To ensure that there is a network of support for nurses across the Cheshire andMerseyside North West Strategic Health Authority.• To ensure appropriate consultation across multi-agencies and multiprofessionalgroups.MembershipAll Hospital Trusts, Primary Care organisations and other relevant stakeholders withinCheshire and Merseyside North West Strategic Health Authority were invited to take part inthe development of these guidelines.Chair/ReportingThe chair will be a Director of Nursing from within Cheshire and Merseyside North WestStrategic Health Authority. The group will report to the Directors of Nursing Group atCheshire and Merseyside North West Strategic Health Authority.Use of the GuidelinesThis document contains several guidelines which can be utilised as required.The CINs group hereby assert their moral rights tothe works herein in accordance with the Data Protection Act 1988.Policy review date 01/10/10
Page 3: Intravenous Access Care and Mainten
Page 8 and 9: Open sterile pack, allowing inner p
Page 10 and 11: Ensure all equipment is gathered be
Page 12 and 13: Skin Tunnelled Catheters - Blood Sa
Page 14 and 15: catheter.• Ensure that the cathet
Page 16 and 17: • Open sterile pack allowing inne
Page 18 and 19: Algorithm persistent withdrawal occ
Page 20 and 21: The CINs group hereby assert their
Page 22 and 23: Care and Maintenance of a non tunne
Page 24 and 25: Central Non-Tunnelled Catheters - S
Page 26 and 27: Central Non-Tunnelled Catheters - B
Page 28 and 29: Central Venous Non-Tunnelled Cathet
Page 30 and 31: Algorithm persistent withdrawal occ
Page 32 and 33: 31References.1. Department of Healt
Page 34 and 35: • Open sterile pack, allowing inn
Page 36 and 37: • Open out sterile pack to create
Page 38 and 39: 37Peripherally Inserted Central Cat
Page 42 and 43: • Place 0.9% sodium chloride (sal
Page 44 and 45: References431. Department of Health
Page 46 and 47: Care and Maintenance of a Periphera
Page 48 and 49: Peripheral Midline - 0.9% Sodium Ch
Page 50 and 51: 49Peripheral Midline -Administratio
Page 54 and 55:
The CINs group hereby assert their
Page 56 and 57:
Put on sterile glovesPlace sterile
Page 58 and 59:
ampoule(s) near to the working area
Page 60 and 61:
59Totally Implanted Venous Access D
Page 62 and 63:
If TIVAD was accessed for flushing
Page 64 and 65:
solution or open Chlorhexidine impr
Page 66 and 67:
65Care and Management of Peripheral
Page 68 and 69:
67Changing a Needle-free I/V access
Page 70 and 71:
69EXIT SITE INFLAMMATION/PHLEBITISP
Page 72 and 73:
SYSTEMIC INFECTION71Signs & Symptom
Page 74 and 75:
FOR CARE OF PERIPHERAL VENOUS CANNU
Page 76 and 77:
Bleeding from site / lineitself.Lin
Page 78 and 79:
77Type of device Risks Actions Vari
Page 80 and 81:
EVALUATION RECORD79DATE EVALUATION
Page 82 and 83:
Type of device Risks Actions Variat
Page 84 and 85:
EVALUATION RECORD83DATE EVALUATION
Page 86 and 87:
Page 88 and 89:
87EVALUATION RECORDDATE EVALUATION
Page 90 and 91:
Page 92 and 93:
91EVALUATION RECORDDATE EVALUATION
Page 94 and 95:
2List of contributors to the Venous
Page 96 and 97:
4PCTcoordinatorMalcolm Smith Mid Ch
Page 98 and 99:
6University Hospital Aintree NHS Fo
Page 100 and 101:
81. IntroductionThe purpose of this
Page 102 and 103:
venous shock, flare or phlebitis. S
Page 104 and 105:
12Hyaluronidase: Dilute 1500 units
Page 106 and 107:
scheme is co-ordinated through the
Page 108 and 109:
16Appendix 2Specific antidotes in t
Page 110 and 111:
experience. Due to the volume of th
Page 112:
20G. Infiltrate the site with 1-3ml
show all

Collaborative Intravenous Nursing Service (CINS) Guidelines

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?